Teva Pharmaceutical Industries TEVA
NYSE TEVA
$36.53 -0.23 (-0.63%)
As of: Sep 9, 2026 · 1:48 PM EDT

Teva Pharmaceutical Industries (TEVA) Prepaid Assets (2009 - 2026)

Teva Pharmaceutical Industries' (TEVA) quarterly Prepaid Assets came in at $1.0 billion in Q2 2026, down 4.61% on a YoY basis from $1.1 billion in Q2 2025, and down 3.36% quarter-over-quarter from $1.1 billion in Q1 2026.

Analysis

Teva Pharmaceutical Industries (TEVA) Prepaid Assets (2009 - 2026) Analysis & Trends

Teva Pharmaceutical Industries (TEVA) has reported Prepaid Assets for 14 consecutive years, with $1.0 billion the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Prepaid Assets fell 4.61% year-over-year to $1.0 billion; the trailing twelve-month figure through Jun 2026 stood at $1.0 billion (down 4.61% YoY), and the FY2025 full-year result was $1.1 billion, up 11.53% from the prior year.
  • Prepaid Assets slipped to $1.0 billion in Q2 2026 per TEVA's latest filing, from $1.1 billion in the prior quarter.
  • Across five years, Prepaid Assets topped out at $1.3 billion in Q1 2024 and bottomed at $1.0 billion in Q4 2024.
  • Historically, Prepaid Assets has averaged $1.1 billion across 5 years, with a median of $1.1 billion in 2024.
  • The sharpest annual moves came in 2023 and 2025: Prepaid Assets grew 17.76% in 2023, then dropped 23.8% in 2025.
  • Over 5 years, Prepaid Assets stood at $1.2 billion in 2022, then rose by 8.0% to $1.3 billion in 2023, then declined by 19.84% to $1.0 billion in 2024, then gained by 11.53% to $1.1 billion in 2025, then declined by 7.84% to $1.0 billion in 2026.
  • According to Business Quant data, Prepaid Assets over the past three periods registered $1.0 billion, $1.1 billion, and $1.1 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.56 Bn 38.90 Bn 2.15 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.86 Bn 9.69 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.46 Bn 5.33 Bn 334.51 Mn
5 Bausch Health Companies 2.37 Bn 528.25 Mn 2.10 Bn
6 Alvotech 1.51 Bn 1.37 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 992.90 Mn 702.78 Mn 93.47 Mn
9 Fennec Pharmaceuticals 411.43 Mn 370.18 Mn 17.15 Mn
10 RedHill Biopharma 181.39 Mn 181.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.03 Bn
Mar 31, 2026 1.07 Bn
Dec 31, 2025 1.12 Bn
Sep 30, 2025 1.12 Bn
Jun 30, 2025 1.08 Bn
Mar 31, 2025 1.02 Bn
Dec 31, 2024 1.01 Bn
Sep 30, 2024 1.13 Bn
Jun 30, 2024 1.10 Bn
Mar 31, 2024 1.34 Bn
Dec 31, 2023 1.26 Bn
Sep 30, 2023 1.17 Bn
Jun 30, 2023 1.23 Bn
Mar 31, 2023 1.25 Bn
Dec 31, 2022 1.16 Bn
Sep 30, 2022 1.05 Bn
Jun 30, 2022 1.05 Bn
Mar 31, 2022 1.06 Bn
Dec 31, 2021 1.08 Bn
Sep 30, 2021 1.07 Bn